During the past decade, Springmill Medical Center conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 20 clinical trials were completed, i.e. on average, 58.8% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 15 clinical trials were completed. i.e. 375% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Springmill Medical Center" #1 sponsor was "SWOG Cancer Research Network" with 11 trials, followed by "National Cancer Institute (NCI)" with 10 trials sponsored, "Pfizer" with 6 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Springmill Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 22 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Medivation, Inc." with 3 trials as a collaborator, "Astellas Pharma Inc" with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Springmill Medical Center" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Breast Cancer" (4 trials), "HER2/Neu Negative" (4 trials) and "Invasive Breast Carcinoma" (4 trials). Many other conditions were trialed in "Springmill Medical Center" in a lesser frequency.

Most popular intervention types in "Springmill Medical Center" are "Drug" (34 trials), "Other" (28 trials), "Biological" (11 trials), "Procedure" (7 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (17 trials), "Quality-of-Life Assessment" (8 trials), "Docetaxel" (6 trials), "Nivolumab" (6 trials) and "Biospecimen Collection" (4 trials). Other intervention names were less common.

The vast majority of trials in "Springmill Medical Center" are 35 trials for "All" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "Springmill Medical Center". undefined are not yet recruiting, 4 are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Springmill Medical Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Springmill Medical Center, 0 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".